Company Events & EarningsExtended setdeferredNew

Maude Device Alert Short

Updated dailyData needs: mediumshort only
paper
2014
Source
Lerner, J., Beard, T.R. & Sgouros, T. (2014). "The economic impact of FDA Drug Safety Communications on pharmaceutical equity prices." Journal of Health Economics, 36, 100-114. (Applied to MAUDE device-AE data - analog of FAERS.)
Read the paper →

In plain terms

When a medical-device maker accumulates safety reports, we short the stock - pending MAUDE database ingest.

How it works

Surge in MAUDE (Manufacturer and User Facility Device Experience) adverse-event reports predicts FDA Safety Communication or Class I/II recall; sponsor stock reprices -8% event-day, -12% over 6mo.

No live results for this strategy yet. Charts appear once it has earned a top spot on at least one stock, either on its own or as part of a blend of several strategies.
Loading substrate evidence…

Data dependencies

  • Daily prices

    Adjusted-close OHLCV for every US-listed ticker; primary price feed.

  • Fda maude device severity daily

    A data feed this strategy reads, refreshed on its normal schedule.

Expected edge

Reported return
-8% event-day, -12% 6mo
Tested over
T+1 to T+40d

Lerner-Beard-Sgouros 2014 analog: -8% event-day, -12% over 6mo on device-recall trigger.

Example tickers where this is likely to fire

Illustrative only, the signal fires based on the live data, not a fixed list.

Related families

Explore Maude Device Alert Short on alphactor.ai

See which tickers this family is currently firing on, with live signals and rankings.

For informational and educational purposes only. Not financial advice. Learn more